About the Foundation

NEWS OF THE XXIII RUSSIAN ONCOLOGY CONGRESS

В первый день XXIII Российского онкологического конгресса РакФонд и Российское общество клинической онкологии провели совместный мастер-класс, посвященный клиническим исследованиям в онкологии далее...

RAKFOND AND RUSSCO AWARD FOR THE BEST RESEARCH

Today, November 12, at the opening ceremony of the XXIII Russian Oncology Congress, the results of the selection of the best research presented at the session “Russian Research Results” were announced. далее...

The 2019 Nobel Prize Laureates in Physiology or Medicine

The announcement of the 2019 Nobel Prize laureates started on October 7, 2019. The 2019 Nobel Prize in Physiology or Medicine is awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza “for their discoveries of how cells sense and adapt to oxygen availability.”  далее...

ANNUAL CANCER PROGRESS REPORT ISSUED BY THE AMERICAN ASSOCIATION FOR CANCER RESEARCH

This September, the American Association for Cancer Research (AACR) released its annual Cancer Progress Report, which highlights advances over the past year in the prevention, detection, diagnosis, and treatment of cancer.  далее...

ANNUAL CANCER PROGRESS REPORT ISSUED BY THE AMERICAN ASSOCIATION FOR CANCER RESEARCH

This September, the American Association for Cancer Research (AACR) released its annual Cancer Progress Report, which highlights advances over the past year in the prevention, detection, diagnosis, and treatment of cancer.  далее...

PRESENTATION OF THE STUDY SUPPORTED BY RAKFOND AT 2019 ASCO ANNUAL MEETING

Final results of the randomized phase II trial of olanzapine versus aprepitant in patients receiving high-emetogenic chemotherapy were presented by its author Dr. Alexey Rumyantsev at the Annual Meeting of the American Society of Clinical Oncology (ASCO) during the Symptoms and Survivorship session on June 3, 2019, in Chicago, USA... далее...

NEWS OF THE 2019 ASCO ANNUAL MEETING: PART II

Compiled by Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting... далее...

NEWS OF THE 2019 ASCO ANNUAL MEETING: PART I

The American Society of Clinical Oncology (ASCO) Annual Meeting took place at the beginning of June in Chicago, USA. Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting, has put together the main news of the meeting... далее...

Interview with Tatiana Semiglazova

Interview with Tatiana Semiglazova, MD, DSci, Professor, Head of Department of Innovative Methods of Therapeutic Oncology and Rehabilitation, N.N. Petrov National Medical Research Center of Oncology (St. Petersburg, Russia), Professor at the Department of Oncology, I.I. Mechnikov North-Western State Medical University (St. Petersburg, Russia)...The topic of the interview is the rehabilitation of cancer patients... далее...

Interview with Andrei Gudkov

Interview with Andrei Gudkov, Ph.D., D.Sci., Senior Vice President, Research Technology and Innovation, Chair, Cell Stress Biology, Roswell Park Comprehensive Cancer Center (Buffalo, USA), Member of RakFond's Scientific Advisory Board... Learn about the relationship between cancer and evolution, what the scientists may be proud of, and where the curiosity leads us... далее...

Interview with Jacek Gronwald

Interview with Jacek Gronwald, PhD, Professor, Department of Genetics and Pathology, Pomeranian Medical University (Szczecin, Poland), Member of RakFond's Scientific Advisory Board. Learn about hereditary cancers, studies of lifestyle factors in oncology... далее...

Interview with Alexey Danilov

Interview with Alexey Danilov, Associate Professor of Medicine, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University (Portland, USA), Member of RakFond's Scientific Advisory Board...Learn about research translation from bench to bedside, the discovery and research of the novel therapies in hematologic malignancies... далее...